Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Zyprexa – Schizophrenia treatment

Drug (Brand / Generic)

Zyprexa / olanzapine

Company / Licensee

Eli Lilly

Therapy Class

Atypical antipsychotic

Product Description

Possible receptor antagonist

Current Indication

Treatment of schizophrenia, psychotic disorders and bipolar disorders

Market Sector

CNS

Development Status

Approved in full in US January 2004, as part of Symbyax in March 2009, patent expires in 2011
Expand
Close
Close
Close

Go Top